Annual Shareholders Equity
$3.60 B
+$620.59 M+20.85%
30 December 2023
Summary:
Charles River Laboratories International annual stockholders equity is currently $3.60 billion, with the most recent change of +$620.59 million (+20.85%) on 30 December 2023. During the last 3 years, it has risen by +$1.48 billion (+70.10%). CRL annual shareholders equity is now at all-time high.CRL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$3.78 B
+$59.54 M+1.60%
28 September 2024
Summary:
Charles River Laboratories International quarterly stockholders equity is currently $3.78 billion, with the most recent change of +$59.54 million (+1.60%) on 28 September 2024. Over the past year, it has increased by +$476.28 million (+14.41%). CRL quarterly shareholders equity is now at all-time high.CRL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +20.9% | +14.4% |
| 3 y3 years | +70.1% | +55.9% |
| 5 y5 years | +173.0% | +146.8% |
CRL Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +70.1% | at high | +55.9% |
| 5 y | 5 years | at high | +173.0% | at high | +146.8% |
| alltime | all time | at high | +3365.7% | at high | +3502.2% |
Charles River Laboratories International Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $3.78 B(+1.6%) |
| June 2024 | - | $3.72 B(+2.3%) |
| Mar 2024 | - | $3.64 B(+1.2%) |
| Dec 2023 | $3.60 B(+20.9%) | $3.60 B(+8.8%) |
| Sept 2023 | - | $3.31 B(+1.7%) |
| June 2023 | - | $3.25 B(+4.6%) |
| Mar 2023 | - | $3.11 B(+4.4%) |
| Dec 2022 | $2.98 B(+17.4%) | $2.98 B(+13.3%) |
| Sept 2022 | - | $2.63 B(-0.8%) |
| June 2022 | - | $2.65 B(+1.4%) |
| Mar 2022 | - | $2.61 B(+3.0%) |
| Dec 2021 | $2.53 B(+19.9%) | $2.53 B(+4.5%) |
| Sept 2021 | - | $2.43 B(+4.7%) |
| June 2021 | - | $2.32 B(+6.2%) |
| Mar 2021 | - | $2.18 B(+3.3%) |
| Dec 2020 | $2.11 B(+29.4%) | $2.11 B(+11.5%) |
| Sept 2020 | - | $1.90 B(+8.2%) |
| June 2020 | - | $1.75 B(+6.1%) |
| Mar 2020 | - | $1.65 B(+1.1%) |
| Dec 2019 | $1.63 B(+24.1%) | $1.63 B(+6.7%) |
| Sept 2019 | - | $1.53 B(+5.3%) |
| June 2019 | - | $1.46 B(+4.1%) |
| Mar 2019 | - | $1.40 B(+6.1%) |
| Dec 2018 | $1.32 B(+26.1%) | $1.32 B(+5.1%) |
| Sept 2018 | - | $1.25 B(+6.0%) |
| June 2018 | - | $1.18 B(+3.7%) |
| Mar 2018 | - | $1.14 B(+9.1%) |
| Dec 2017 | $1.05 B(+24.9%) | $1.05 B(+2.3%) |
| Sept 2017 | - | $1.02 B(+6.0%) |
| June 2017 | - | $963.50 M(+9.9%) |
| Mar 2017 | - | $876.43 M(+4.7%) |
| Dec 2016 | $836.77 M(+14.1%) | $836.77 M(-3.6%) |
| Sept 2016 | - | $867.97 M(+4.4%) |
| June 2016 | - | $831.35 M(+6.6%) |
| Mar 2016 | - | $779.82 M(+6.4%) |
| Dec 2015 | $733.07 M(+9.1%) | $733.07 M(+4.1%) |
| Sept 2015 | - | $704.36 M(+0.4%) |
| June 2015 | - | $701.70 M(+5.7%) |
| Mar 2015 | - | $663.71 M(-1.3%) |
| Dec 2014 | $672.20 M(+4.9%) | $672.20 M(+0.3%) |
| Sept 2014 | - | $670.30 M(-0.2%) |
| June 2014 | - | $671.82 M(-3.4%) |
| Mar 2014 | - | $695.46 M(+8.5%) |
| Dec 2013 | $640.98 M(+6.7%) | $640.98 M(-2.4%) |
| Sept 2013 | - | $656.51 M(+1.3%) |
| June 2013 | - | $647.95 M(+3.1%) |
| Mar 2013 | - | $628.28 M(+4.6%) |
| Dec 2012 | $600.80 M | $600.80 M(+0.5%) |
| Sept 2012 | - | $597.71 M(+6.2%) |
| June 2012 | - | $562.84 M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $552.60 M(+5.1%) |
| Dec 2011 | $525.58 M(-23.5%) | $525.58 M(-2.6%) |
| Sept 2011 | - | $539.71 M(-8.4%) |
| June 2011 | - | $589.09 M(+4.6%) |
| Mar 2011 | - | $562.92 M(-18.1%) |
| Dec 2010 | $687.42 M(-50.0%) | $687.42 M(-34.0%) |
| Sept 2010 | - | $1.04 B(-25.5%) |
| June 2010 | - | $1.40 B(+0.8%) |
| Mar 2010 | - | $1.39 B(+0.8%) |
| Dec 2009 | $1.38 B(+14.7%) | $1.38 B(+1.9%) |
| Sept 2009 | - | $1.35 B(+5.2%) |
| June 2009 | - | $1.28 B(+5.4%) |
| Mar 2009 | - | $1.22 B(+1.6%) |
| Dec 2008 | $1.20 B(-35.6%) | $1.20 B(-38.4%) |
| Sept 2008 | - | $1.95 B(+0.1%) |
| June 2008 | - | $1.95 B(+1.9%) |
| Mar 2008 | - | $1.91 B(+2.7%) |
| Dec 2007 | $1.86 B(+16.6%) | $1.86 B(+3.2%) |
| Sept 2007 | - | $1.80 B(+4.2%) |
| June 2007 | - | $1.73 B(+5.3%) |
| Mar 2007 | - | $1.64 B(+2.9%) |
| Dec 2006 | $1.60 B(-12.7%) | $1.60 B(+2.7%) |
| Sept 2006 | - | $1.55 B(-5.3%) |
| June 2006 | - | $1.64 B(-5.5%) |
| Mar 2006 | - | $1.74 B(-4.9%) |
| Dec 2005 | $1.83 B(+24.1%) | $1.83 B(+2.3%) |
| Sept 2005 | - | $1.79 B(+3.1%) |
| June 2005 | - | $1.73 B(+14.1%) |
| Mar 2005 | - | $1.52 B(+3.1%) |
| Dec 2004 | $1.47 B(+216.9%) | $1.47 B(+167.3%) |
| Sept 2004 | - | $550.82 M(+6.1%) |
| June 2004 | - | $519.06 M(+5.1%) |
| Mar 2004 | - | $494.00 M(+6.3%) |
| Dec 2003 | $464.62 M(+30.0%) | $464.62 M(+7.6%) |
| Sept 2003 | - | $431.94 M(+4.9%) |
| June 2003 | - | $411.70 M(+8.2%) |
| Mar 2003 | - | $380.35 M(+6.4%) |
| Dec 2002 | $357.38 M(+23.4%) | $357.38 M(+7.4%) |
| Sept 2002 | - | $332.84 M(+7.5%) |
| June 2002 | - | $309.54 M(+7.3%) |
| Mar 2002 | - | $288.41 M(-0.4%) |
| Dec 2001 | $289.51 M(+141.5%) | $289.51 M(+4.3%) |
| Sept 2001 | - | $277.67 M(+33.4%) |
| June 2001 | - | $208.22 M(+4.6%) |
| Mar 2001 | - | $199.14 M(+66.1%) |
| Dec 2000 | $119.86 M(-208.8%) | $119.86 M(+6.0%) |
| Sept 2000 | - | $113.09 M(-204.1%) |
| June 2000 | - | -$108.66 M(-2.3%) |
| Mar 2000 | - | -$111.17 M |
| Dec 1999 | -$110.14 M(-165.5%) | - |
| Dec 1998 | $168.26 M | - |
FAQ
- What is Charles River Laboratories International annual stockholders equity?
- What is the all time high annual shareholders equity for Charles River Laboratories International?
- What is Charles River Laboratories International annual shareholders equity year-on-year change?
- What is Charles River Laboratories International quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly shareholders equity year-on-year change?
What is Charles River Laboratories International annual stockholders equity?
The current annual shareholders equity of CRL is $3.60 B
What is the all time high annual shareholders equity for Charles River Laboratories International?
Charles River Laboratories International all-time high annual stockholders equity is $3.60 B
What is Charles River Laboratories International annual shareholders equity year-on-year change?
Over the past year, CRL annual stockholders equity has changed by +$620.59 M (+20.85%)
What is Charles River Laboratories International quarterly stockholders equity?
The current quarterly shareholders equity of CRL is $3.78 B
What is the all time high quarterly shareholders equity for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly stockholders equity is $3.78 B
What is Charles River Laboratories International quarterly shareholders equity year-on-year change?
Over the past year, CRL quarterly stockholders equity has changed by +$476.28 M (+14.41%)